TuisHIMS • NYSE
add
Hims & Hers Health Inc
Vorige sluiting
$51,76
Dagwisseling
$50,25 - $55,93
Jaarwisseling
$15,73 - $72,98
Markkapitalisasie
12,54 mjd USD
Gemiddelde volume
29,60 m
P/V-verhouding
69,73
Dividend-opbrengs
-
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 544,83 m | 72,61% |
Bedryfskoste | 389,47 m | 58,62% |
Netto inkomste | 42,50 m | 219,66% |
Netto winsgrens | 7,80 | 85,27% |
Wins per aandeel | 0,29 | 80,09% |
EBITDA | 37,19 m | 152,77% |
Effektiewe belastingkoers | -29,38% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 1,14 mjd | 403,59% |
Totale bates | 1,88 mjd | 290,76% |
Totale aanspreeklikheid | 1,31 mjd | 1 009,29% |
Totale ekwiteit | 562,70 m | — |
Uitstaande aandele | 226,02 m | — |
Prys om te bespreek | 20,79 | — |
Opbrengs op bates | 4,82% | — |
Opbrengs op kapitaal | 6,02% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 42,50 m | 219,66% |
Kontant van bedrywe | -19,12 m | -135,67% |
Kontant van beleggings | -21,09 m | -371,77% |
Kontant van finansiering | 889,17 m | 3 647,45% |
Netto kontantverandering | 849,99 m | 3 433,09% |
Beskikbare kontantvloei | -81,24 m | -311,84% |
Meer oor
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
Hims & Hers operates with a direct-to-consumer model. Consumers consult licensed healthcare professionals and access treatments and products through the company's platform. Customers pay for a consultation with a doctor to prescribe the drug along with the price of the drug itself. The company has expanded its offerings to include health solutions for both men and women, along with mental health services. Wikipedia
Gestig
Nov. 2017
Webwerf
Werknemers
1 637
